Repligen Corp. (RGEN)
117.29
-0.49
(-0.42%)
USD |
NASDAQ |
Apr 06, 14:29
Repligen Price : 117.29 for April 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Masimo Corp. | 178.34 |
| Orthofix Medical, Inc. | 11.79 |
| InfuSystem Holdings, Inc. | 9.53 |
| Tandem Diabetes Care, Inc. | 18.75 |
| Plus Therapeutics, Inc. | 3.30 |
Price Related Metrics
| PE Ratio | 135.67 |
| PS Ratio | 8.987 |
| Price to Book Value | 3.137 |
| Price to Free Cash Flow | 72.36 |
| Earnings Yield | 0.74% |
| Market Cap | 6.577B |
| Operating PE Ratio | 130.34 |
| Normalized PE Ratio | 143.74 |